收藏切换
Application of health technology assessment in selection of third-generation anti-seizure medications perampanel and lacosamide
收藏切换
PDF
Zhi-hui HUA, Yi ZHANG, Yuan FANG, Xiu-mei LIU, Qing-yu YANG, Chun-li GE, Nan CHEN
Chinese Journal of New Drugs and Clinical Remedies | 2024, 43(5) : 380 - 386
Less
收藏切换
Chinese Journal of New Drugs and Clinical Remedies | 2024, 43(5): 380-386
Original Article
Application of health technology assessment in selection of third-generation anti-seizure medications perampanel and lacosamide
Full
Zhi-hui HUA, Yi ZHANG, Yuan FANG, Xiu-mei LIU, Qing-yu YANG, Chun-li GE, Nan CHEN
Affiliations
  • Department of Pharmacy, the Fifth Clinical Medical College of He-nan University of Chinese Medicine/ Zhengzhou People’s Hospital, Zhengzhou HE-NAN 450003, China
Published: 2024-05-25 doi: 10.14109/j.cnki.xyylc.2024.05.12
Outline
收藏切换
AIM

To provide reference for selection and clinical rational use of third-generation anti-seizure medications in medical institutions through a comprehensive evaluation of perampanel and lacosamide.

METHODS

A percentage based evaluation system was developed based on the Quick Guide for Drug Evaluation and Selection in Chinese Medical Institutions (the Second Edition). Referring to drug instructions, clinical treatment guidelines, and relevant literature, perampanel and lacosamide were quantitatively scored from five dimensions of pharmaceutical characteristics,effectiveness, safety, economy, and other attributes.

RESULTS

The final evaluation score was 77.41 for perampanel and 69.06 for lacosamide. The score of perampanel was higher than 70, so the recommendation for entering the drug use catalog of medical institutions was “strong recommendation”. There was a significant difference in effectiveness and economy between the two drugs. Perampanel had more evidence-based proofs and indications for the treatment of drug-resistant epilepsy and lower average daily treatment cost, so the effectiveness and economy of perampanel was slightly better than that of lacosamide. However, in terms of safety, perampanel had a Boxed Warning from the U. S. Food and Drug Administration about severe psychiatric and behavioral reactions, and it was not as recommended as lacosamide in patients with pregnancy or liver dysfunction.

CONCLUSION

Perampanel and lacosamide each have advantages in different attributes, and medical institutions can decide whether to introduce them based on the characteristics of patient population and the availability of alternative drugs.

perampanel  /  lacosamide  /  antiepileptic agents  /  drug evaluation  /  drug selection
Zhi-hui HUA, Yi ZHANG, Yuan FANG, Xiu-mei LIU, Qing-yu YANG, Chun-li GE, Nan CHEN. Application of health technology assessment in selection of third-generation anti-seizure medications perampanel and lacosamide[J]. Chinese Journal of New Drugs and Clinical Remedies, 2024 , 43 (5) : 380 -386 . DOI: 10.14109/j.cnki.xyylc.2024.05.12
Year 2024 volume 43 Issue 5
PDF
141
65
Cite this Article
BibTeX
Article Info
doi: 10.14109/j.cnki.xyylc.2024.05.12
  • Receive Date:2023-04-20
  • Online Date:2026-03-20
  • Published:2024-05-25
Article Data
Affiliations
History
  • Received:2023-04-20
  • Accepted:2024-01-26
Funding
Affiliations
    Department of Pharmacy, the Fifth Clinical Medical College of He-nan University of Chinese Medicine/ Zhengzhou People’s Hospital, Zhengzhou HE-NAN 450003, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyylczz/EN/10.14109/j.cnki.xyylc.2024.05.12
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT